Holen Sie sich die Stockscreener-App
0.5394
9.95%
-0.0596
Vorhandelsmarkt:
.55
0.0106
+1.97%
Scisparc Ltd Aktie (SPRC) Neueste Nachrichten
Minerva Neurosciences (NASDAQ:NERV) vs. SciSparc (NASDAQ:SPRC) Financial Contrast - Defense World
SciSparc gets Nasdaq extension to regain compliance - MSN
SciSparc (NASDAQ:SPRC) Stock Quotes, Forecast and News Summary - Benzinga
SciSparc Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement - GlobeNewswire
SciSparc Ltd. Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing - Marketscreener.com
SciSparc, Automax enters direct import market with $13M first shipment of JAC EVs - MSN
SPRCSciSparc Ltd. Ordinary Shares Latest Stock News & Market Updates - StockTitan
SciSparc Granted Nasdaq Compliance Extension - TipRanks
SciSparc Secures Critical Nasdaq Extension to Meet $1 Minimum Bid Requirement - StockTitan
SciSparc: AutoMax Enters the Direct Import Market with a $13 Million First Shipment of JAC Electric Vehicles - GlobeNewswire
SciSparc's AutoMax Secures First $13M JAC Motors EV Shipment for Israeli Market Launch - StockTitan
SciSparc says MitoCareX expands research to pancreatic cancer - Yahoo Finance
SciSparc Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 - Marketscreener.com
Scisparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment - Marketscreener.com
SciSparc: MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Positive Results - GlobeNewswire
SciSparc's MitoCareX Breakthrough: AI-Powered Platform Shows Promise in Pancreatic Cancer Treatment - StockTitan
SciSparc and Clearmind Medicine Advance with European Patent Application for Psychedelic Binge Behavior Treatment - TipRanks
Nasdaq Surges Over 200 Points; BioLineRx Shares Plummet - Benzinga
Why Is Psychedelic-SciSparc Stock Trading Higher On Monday? - AOL
Stock market today: AEON Biopharma saw gain of 255.62% while SciSparc increased by 89.77% in early trading - Business Upturn
SciSparc-Clearmind Medicine Collaboration Announces the - GlobeNewswire
SciSparc and Clearmind Secure European Patent for Groundbreaking Binge Behavior Treatment - StockTitan
SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination Treatment - The Manila Times
IMCA renews SciSparc’s autism spectrum disorder therapy trial approval - Yahoo Finance
SciSparc Secures Approval Renewal for Autism Treatment Trial - TipRanks
SciSparc announces renewal of approval by Israeli Medical Cannabis Agency - TipRanks
SciSparc Announces Renewal of Approval by Israeli Medical - GlobeNewswire
SciSparc Advances Autism Treatment Trial: CBD-Based SCI-210 Gets Key Israeli Approval for Children's Study - StockTitan
Scisparc Ltd. Announces Initiation of Patient Recruitment for Its Clinical Trial with Sci-210 in Children with Autism Spectrum Disorder - Marketscreener.com
SciSparc: AutoMax announces $13M first delivery of JAC vehicles - Yahoo Finance
SciSparc Supports AutoMax’s $13 Million JAC Motors Vehicle Import - TipRanks
S&P 500 Edges Lower, SciSparc Shares SurgeSEALSQ (NASDAQ:LAES), Baosheng Media Gr (NASDAQ:BAOS) - Benzinga
Stock market today: Millennium Group International surged by 318.96% while SciSparc increased by 153.01% in early trading - Business Upturn
SciSparc Shares Skyrocket With AutoMax's First JAC Motors Shipment - Yahoo Finance
SciSparc: AutoMax Announces $13 Million First Delivery of - GlobeNewswire
SciSparc's AutoMax Receives First $13M JAC Motors Shipment Following Israel Import Approval - StockTitan
SciSparc Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 - Marketscreener.com
Scisparc Ltd. with Clearmind Medicine Inc. Publishes for the Innovative Combination of 3,4-Methylenedioxymethamphetamine with N-Acylethanolamines - Marketscreener.com
SciSparc Ltd. Announces Finalize an Exclusive Patent License Agreement with Polyrizon Ltd - Marketscreener.com
Clearmind Medicine Inc. Announces Publication of International Patent Application for Innovative MDMA-Based Combination Treatment - Marketscreener.com
Scisparc Ltd. and Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination Therapy - Marketscreener.com
SciSparc Ltd. Announces U.S. Patent Application for Treating Metabolic Syndrome and Weight Loss - Marketscreener.com
SPRC stock touches 52-week low at $0.21 amid sharp decline - Investing.com Canada
SPRC stock touches 52-week low at $0.21 amid sharp decline By Investing.com - Investing.com South Africa
SciSparc Announces Spin-Off Plans with Miza III Ventures - TipRanks
SciSparc amends non-binding LOI to spin-off advanced clinical stage portfolio - TipRanks
SciSparc Provides Updates on Status of Spin-off of its - GlobeNewswire
SciSparc Advances $11.6M Pharma Portfolio Spin-Off Deal with Miza Ventures, Retaining 84% Control - StockTitan
SciSparc Ltd. to Acquire AutoMax Motors Ltd. - TipRanks
SciSparc Extends Merger Deadline with AutoMax Motors - TipRanks
SciSparc Ltd. Enters into Letter of Intent with Jeffs' Brands Ltd - Marketscreener.com
SciSparc Ltd. Reports Changes in Financial Position - TipRanks
SciSparc Ltd. Gains Shareholder Approval for Proposals - TipRanks
4.81%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):